Cet ouvrage fait partie de la bibliothèque YouScribe
Obtenez un accès à la bibliothèque pour le lire en ligne
En savoir plus

Brazilian Healthcare Industry Thrives in Favorable Socioeconomic Environment, Finds Frost & Sullivan

2 pages
Brazilian Healthcare Industry Thrives in Favorable Socioeconomic Environment, Finds Frost & Sullivan PR Newswire BUENOS AIRES, Argentina, Aug. 28, 2012 -- Scope for industry expansion gives participants the freedom to innovate BUENOS AIRES, Argentina, Aug. 28, 2012 /PRNewswire/ -- A complex and diverse set of forces such as government investments, consolidation of the middle class, and high disease burden will fortify Brazil's position as a top-rung market in the global healthcare industry. A mesh of socioeconomic and demographic trends create significant opportunities for local and multinational companies in both healthcare and non-healthcare sectors, and will stoke double-digit growth rates by 2015. One of the biggest gainers will be the pharmaceuticals and biotechnology sector, which is expected to be the sixth largest in the world in 2015. New analysis from Frost & Sullivan (http://www.healthcare.frost.com), Healthcare Landscape, Outlook, and Growth Opportunities in B r a z i l, finds that the market earned revenues of $32.50 billion in 2011 and estimates this to reach $52.30 billion in 2015. If you are interested in more information on this research, please send an email to Francesca Valente, Corporate Communications, at francesca.valente@frost.com, with your full name, company name, title, telephone number, company email address, company Web site, city, state and country.
Voir plus Voir moins
Brazilian Healthcare Industry Thrives in Favorable Socioeconomic Environment, Finds Frost & Sullivan
PR Newswire BUENOS AIRES, Argentina, Aug. 28, 2012
-- Scope for industry expansion gives participants the freedom to innovate BUENOS AIRES, Argentina,Aug. 28, 2012/PRNewswire/ -- A complex and diverse set of forces such as government investments, consolidation of the middle class, and high disease burden will fortifyBrazil's position as a top-rung market in the global healthcare industry. A mesh of socioeconomic and demographic trends create significant opportunities for local and multinational companies in both healthcare and non-healthcare sectors, and will stoke double-digit growth rates by 2015. One of the biggest gainers will be the pharmaceuticals and biotechnology sector, which is expected to be the sixth largest in the world in 2015. New analysis from Frost & Sullivan (http://www.healthcare.frost.com), Healthcare Landscape, Outlook, and Growth Opportunities inBrazil, finds that the market earned revenues of$32.50 billionin 2011 and estimates this to reach$52.30 billionin 2015. If you are interested in more information on this research, please send an email to Francesca Valente, Corporate Communications, at francesca.valente@frost.com, with your full name, company name, title, telephone number, company email address, company Web site, city, state and country. The Sistema Unico de Saude (SUS),Brazil's unified health system, has significantly increased citizens' access to healthcare with its$176 billionbudget from the Multiannual Plan. "The current positive economic scenario and increase in formal employment in Brazilwill drive healthcare spending and the expansion of private health insurance industry," said Frost & Sullivan Industry Analyst William Fujioka. "Additionally, the higher prevalence of obesity, diabetes, HIV/AIDS, and cancer will provide opportunities for various healthcare stakeholders." While the swelling patient pool attracts investors, complex administrative processes hamper investment, procurement, and care. This necessitates expansion and modernization of the healthcare infrastructure in the country, especially in the public system. Currently, the synergistic processes between philanthropic and private institutions are restricted to large hospitals in the South and Southeast regions. Brazilian hospitals demonstrate a low rate of adoption of new technologies such as magnetic resonance imaging (MRI) and computed tomography (CT), which comprise only 4.1 percent of the total installed base of diagnostic imaging. However, this underserved market enables healthcare companies to offer innovative solutions to consumers, providers, and payers. "Innovation need not necessarily come from technology leaps," noted Fujioka. "Lower costs, differentiation of post-sales services, and ease to use can also fulfill unmet needs in the market."